p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival
Ioannis Diamantis, Eva Karamitopoulou, Elias Perentes, Arthur Zimmermann – 1 September 1995 – Forty‐five extrahepatic bile duct carcinomas (i.e., tumors of the region proximal to the duct junction, including Klatskin tumors, tumors of the lower mid‐region, and tumors of the ampulla of Vater) and 11 gallbladder carcinomas were immunohistochemically examined for p53 protein expression, using the DO‐7 monoclonal (mAb) and the CM‐1 polyvalent (pAb) antibodies and an antigen retrieval method.